Capital Flow Monitor · Sponsors · CIK 2143233
Fresenius Medical Care North Dallas, LLC
C/O FRESENIUS MEDICAL CARE NORTH AMERICA, WALTHAM, MA, 02451 · 781-699-9250
Other Health Care · Limited Liability Company· inc. DELAWARE true 2026
Fit score
—
Offering
$1.0M
Sold
$1.0M
% sold
100.0%
Investors
2
Min investment
$503K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | D ·current | 506(b) | $1.0M | $1.0M | 100.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Erik Lyesiuk — Director, Waltham, MA
7 other raises
- Fresenius Medical Care Council Bluffs, LLC $3.8M of $3.8M · 100.0%
- Fresenius Medical Care Northern Lancaster, LLC $4.6M of $4.6M · 100.0%
- Fresenius Medical Care Conshohocken Home, LLC $3.8M of $3.8M · 100.0%
- Fresenius Medical Care Newark, LLC $4.9M of $4.9M · 100.0%
- Fresenius Medical Care Dubuque, LLC $4.7M of $4.7M · 100.0%
- Fresenius Medical Care Champions, LLC $4.7M of $4.7M · 100.0%
- Fresenius Medical Care Northshore Houston, LLC $4.0M of $4.0M · 100.0%
- Breann Montesanto — Director, Waltham, MA
- Christina Denman — Director, Waltham, MA
- Maryann Carumba — Director, Waltham, NC
-
Geoffrey Walker, M.D. — Director, Dallas, TX
1 other raise
- North Texas Renal Management VIII, LLC $30K of $204K · 14.7%
- Steven M Gieser, M.D. — Director, Dallas, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.